Mariana Caraballo Angelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mariana Caraballo Angelli has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Anna Nonell Amill
Colorectal Unit, General and Digestive Surgery, Hospital Universitari Parc Taulí, 08208 Sabadell, Spain
2 shared publications - Anna Serracant-Barrera
Colorectal Unit, General and Digestive Surgery, Hospital Universitari Parc Taulí, 08208 Sabadell, Spain
2 shared publications - Laura Mora-López
Department of Surgery, Parc Taulí University Hospital, Universitat Autònoma de Barcelona, 08208 Sabadell, Barcelona, Spain
2 shared publications - Victor Admella Clanchet
Colorectal Unit, General and Digestive Surgery, Hospital Universitari Parc Taulí, 08208 Sabadell, Spain
2 shared publications - Albert Garcia Nalda
General Surgery Department. Coloproctology Unit,Parc Tauli University Hospital. Research Institute I3PT. Barcelona Autnomous University,Sabadell,Spain, Spain
1 shared publication - Albert Garcia-Nalda
Colorectal Unit, General and Digestive Surgery, Hospital Universitari Parc Taulí, 08208 Sabadell, Spain
1 shared publication
Latest Publications
- Open Access
Short-Term Surgical Outcomes and Postoperative Safety in Octogenarian Patients Undergoing Colorectal Cancer Resection: A Comparative Cohort Study
Background: Surgical management of colorectal cancer (CRC) in elderly adults presents complex clinical challenges due to baseline multimorbidity and frailty. This study aimed to evaluate short-term surgical safety and postoperative outcomes in carefully selected octogenarian patients (≥80 years) compared with a younger cohort (n = 604) and ≥80 years (n = 138). Clinical characteristics, frailty burden evaluated using the clinician-reported IF-VIG index, surgical techniques, histopathological staging, and 30-day postoperative morbidity were evaluated. Multivariable logistic regression was performed to adjust for potential baseline confounders including ASA status, frailty, surgical approach, and tumor stage. Results: Octogenarians exhibited a significantly higher prevalence of baseline frailty (23.2%, 32/138 evaluated vs. 5.8%, 35/605 evaluated, p < 0.001) and ASA physical status grade III–IV (70.3% vs. 45.7%, p < 0.001). Surgical approaches were comparable in both groups (p = 0.560). Overall, minimally invasive surgery rates (laparoscopic and robotic) reached 92.6% in octogenarians and 95.2% in younger controls. Specifically, robotic-assisted resection was implemented at equal rates between groups (71.1% vs. 71.1%). Overall 30-day postoperative complications were comparable (≥80: 42.0% vs. II: 9.4% vs. 11.1%, p = 0.572). Among patients undergoing primary intestinal anastomosis (n = 632), anastomotic leakage (3.5% vs. 3.1%, p = 0.835) and anastomotic bleeding (9.6% vs. 9.3%, p = 0.920) showed no significant differences. Multivariable logistic regression confirmed that advanced age ≥ 80 years was not an independent predictor of overall morbidity (aOR 0.92, 95% CI 0.60–1.41, p = 0.698). Median length of hospital stay (4 days, p = 0.391), 30-day readmissions (4.4% vs. 4.3%, p = 0.979), and 30-day in-hospital mortality (0.0% vs. 0.3%, p = 0.499) were equivalent. Conclusions: Elective curative-intent CRC resection in carefully selected octogenarians managed within a multidisciplinary pathway incorporating objective frailty assessment, prehabilitation, and minimally invasive techniques yields short-term postoperative outcomes, major complication rates, and hospital stays comparable to younger counterparts. Advanced chronological age alone should not preclude surgical resection in fit or mild-to-moderately frail older adults.
Open AccessShort-Term Surgical Outcomes and Postoperative Safety in Octogenarian Patients Undergoing Colorectal Cancer Resection: A Comparative Cohort Study
Background: Surgical management of colorectal cancer (CRC) in elderly adults presents complex clinical challenges due to baseline multimorbidity and frailty. This study aimed to evaluate short-term surgical safety and postoperative outcomes in carefully selected octogenarian patients (≥80 years) compared with a younger cohort (n = 604) and ≥80 years (n = 138). Clinical characteristics, frailty burden evaluated using the clinician-reported IF-VIG index, surgical techniques, histopathological staging, and 30-day postoperative morbidity were evaluated. Multivariable logistic regression was performed to adjust for potential baseline confounders including ASA status, frailty, surgical approach, and tumor stage. Results: Octogenarians exhibited a significantly higher prevalence of baseline frailty (23.2%, 32/138 evaluated vs. 5.8%, 35/605 evaluated, p < 0.001) and ASA physical status grade III–IV (70.3% vs. 45.7%, p < 0.001). Surgical approaches were comparable in both groups (p = 0.560). Overall, minimally invasive surgery rates (laparoscopic and robotic) reached 92.6% in octogenarians and 95.2% in younger controls. Specifically, robotic-assisted resection was implemented at equal rates between groups (71.1% vs. 71.1%). Overall 30-day postoperative complications were comparable (≥80: 42.0% vs. II: 9.4% vs. 11.1%, p = 0.572). Among patients undergoing primary intestinal anastomosis (n = 632), anastomotic leakage (3.5% vs. 3.1%, p = 0.835) and anastomotic bleeding (9.6% vs. 9.3%, p = 0.920) showed no significant differences. Multivariable logistic regression confirmed that advanced age ≥ 80 years was not an independent predictor of overall morbidity (aOR 0.92, 95% CI 0.60–1.41, p = 0.698). Median length of hospital stay (4 days, p = 0.391), 30-day readmissions (4.4% vs. 4.3%, p = 0.979), and 30-day in-hospital mortality (0.0% vs. 0.3%, p = 0.499) were equivalent. Conclusions: Elective curative-intent CRC resection in carefully selected octogenarians managed within a multidisciplinary pathway incorporating objective frailty assessment, prehabilitation, and minimally invasive techniques yields short-term postoperative outcomes, major complication rates, and hospital stays comparable to younger counterparts. Advanced chronological age alone should not preclude surgical resection in fit or mild-to-moderately frail older adults.
- Open Access
- 14 August 2026
- Published by MDPI AG in Preprints.org
Comparative Analysis of Postoperative Outcomes Between Transanal Total Mesorectal Excision (TaTME) and Robotic Total Mesorectal Excision with TTSS Anastomosis (RTME/TTSSTEO)
Surgical treatment for rectal cancer has evolved to improve outcomes. To this end, we conducted a comparative study analyzing the postoperative, pathological, and oncological outcomes of two techniques for the treatment of mid- and lower rectal cancer: Transanal Total Mesorectal Excision (TaTME) and Robotic Total Mesorectal Excision with TTSS anastomosis using the TEO â platform (RTME/TTSSTEO). A total of 146 patients who underwent surgery between 2012 and 2025 at a tertiary care center were included. Both groups were comparable in baseline characteristics and staging. The robotic technique was associated with longer operative time but a lower overall complication rate and a trend toward fewer clinical suture failures. The quality of the mesorectum and the rate of R0 resections were high in both approaches. At follow-up, local recurrence was lower in the robotic group, although the duration of follow-up was shorter. The results suggest that RTME-TTSSTEO is a safe alternative and potentially superior in terms of overall morbidity and mortality compared to TaTME.
- 14 August 2026
- Published by MDPI AG in Preprints.org
Open AccessComparative Analysis of Postoperative Outcomes Between Transanal Total Mesorectal Excision (TaTME) and Robotic Total Mesorectal Excision with TTSS Anastomosis (RTME/TTSSTEO)
Surgical treatment for rectal cancer has evolved to improve outcomes. To this end, we conducted a comparative study analyzing the postoperative, pathological, and oncological outcomes of two techniques for the treatment of mid- and lower rectal cancer: Transanal Total Mesorectal Excision (TaTME) and Robotic Total Mesorectal Excision with TTSS anastomosis using the TEO â platform (RTME/TTSSTEO). A total of 146 patients who underwent surgery between 2012 and 2025 at a tertiary care center were included. Both groups were comparable in baseline characteristics and staging. The robotic technique was associated with longer operative time but a lower overall complication rate and a trend toward fewer clinical suture failures. The quality of the mesorectum and the rate of R0 resections were high in both approaches. At follow-up, local recurrence was lower in the robotic group, although the duration of follow-up was shorter. The results suggest that RTME-TTSSTEO is a safe alternative and potentially superior in terms of overall morbidity and mortality compared to TaTME.
- Open Access
- 29 July 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (11) , 14645-14655
Bowel dysfunction (LARS) and quality of life after chemoradiotherapy and local excision versus total mesorectal excision in T2–T3ab, N0, M0 rectal cancer: the TAUTEM randomized clinical trial
Background: Bowel dysfunction and quality of life (QoL) are key determinants of long-term outcomes after treatment for localized rectal cancer (cT2–cT3a–b, N0, M0). Total mesorectal excision (TME) provides effective oncologic control but may cause substantial functional impairment. Organ-preserving strategies combining chemoradiotherapy with local excision may improve functional outcomes, yet long-term patient-reported data remain limited. Materials and Methods: TAUTEM is a multicenter, prospective, open-label, phase 3, randomized, noninferiority trial comparing chemoradiotherapy followed by transanal endoscopic microsurgery (CRT–TEM) with standard TME in patients with T2–T3ab, N0, M0 rectal cancer. Long-term bowel function was assessed using the Low Anterior Resection Syndrome (LARS) score ≥24 months after definitive treatment. Quality of life (QoL) was evaluated using the EORTC QLQ-C30, QLQ-CR38, and the Karnofsky Performance Status at baseline and after treatment. Analyses were conducted in the modified intention-to-treat and per-protocol populations. Results: Of 173 randomized patients, 162 were included in the modified intention-to-treat analysis (81 per group). Long-term LARS assessment was available for 96 of 102 eligible patients (94%) at a median follow-up of 87.5 months. Global QoL was higher after CRT–TEM than after TME (median 83.3 vs 66.7; P = 0.02). Permanent stoma rates were lower following CRT–TEM than after TME (7.4% vs 28.4%). Major LARS occurred less frequently after CRT–TEM than after TME (7.7% vs 36.4%; P = 0.001), with higher rates of no LARS (80.8% vs 47.7%; P = 0.001). Item-level outcomes (frequency, urgency, clustering, and flatus incontinence) consistently favored CRT–TEM. Conclusions: CRT–TEM was associated with substantially less long-term bowel dysfunction and superior QoL compared with TME, together with markedly fewer permanent stomas. These findings support organ-preserving strategies for selected patients with cT2–cT3a–b, N0, M0 rectal cancer.
- 29 July 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (11) , 14645-14655
Open AccessBowel dysfunction (LARS) and quality of life after chemoradiotherapy and local excision versus total mesorectal excision in T2–T3ab, N0, M0 rectal cancer: the TAUTEM randomized clinical trial
Background: Bowel dysfunction and quality of life (QoL) are key determinants of long-term outcomes after treatment for localized rectal cancer (cT2–cT3a–b, N0, M0). Total mesorectal excision (TME) provides effective oncologic control but may cause substantial functional impairment. Organ-preserving strategies combining chemoradiotherapy with local excision may improve functional outcomes, yet long-term patient-reported data remain limited. Materials and Methods: TAUTEM is a multicenter, prospective, open-label, phase 3, randomized, noninferiority trial comparing chemoradiotherapy followed by transanal endoscopic microsurgery (CRT–TEM) with standard TME in patients with T2–T3ab, N0, M0 rectal cancer. Long-term bowel function was assessed using the Low Anterior Resection Syndrome (LARS) score ≥24 months after definitive treatment. Quality of life (QoL) was evaluated using the EORTC QLQ-C30, QLQ-CR38, and the Karnofsky Performance Status at baseline and after treatment. Analyses were conducted in the modified intention-to-treat and per-protocol populations. Results: Of 173 randomized patients, 162 were included in the modified intention-to-treat analysis (81 per group). Long-term LARS assessment was available for 96 of 102 eligible patients (94%) at a median follow-up of 87.5 months. Global QoL was higher after CRT–TEM than after TME (median 83.3 vs 66.7; P = 0.02). Permanent stoma rates were lower following CRT–TEM than after TME (7.4% vs 28.4%). Major LARS occurred less frequently after CRT–TEM than after TME (7.7% vs 36.4%; P = 0.001), with higher rates of no LARS (80.8% vs 47.7%; P = 0.001). Item-level outcomes (frequency, urgency, clustering, and flatus incontinence) consistently favored CRT–TEM. Conclusions: CRT–TEM was associated with substantially less long-term bowel dysfunction and superior QoL compared with TME, together with markedly fewer permanent stomas. These findings support organ-preserving strategies for selected patients with cT2–cT3a–b, N0, M0 rectal cancer.